PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-0.99%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$62.4M
AUM Growth
+$62.4M
(-19%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-20.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Cartesian Therapeutics
RNAC
|
$12.6M |
| 2 |
Dare Bioscience
DARE
|
$2 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $49.5M | 79.24% | 569,889 | – | – |
|
2
Lyra Therapeutics
LYRA
$11.5M
| $8.84M | 14.16% | 1,100,852 | – | – |
|
3
X4 Pharmaceuticals
XFOR
$84.2M
| $2.03M | 3.24% | 311,492 | – | – |
|
|
ATYR
4
aTyr Pharma
ATYR
$527M
| $637K | 1.02% | 130,572 | – | – |
|
|
5
Dare Bioscience
DARE
$27.2M
| $617K | 0.99% | 326,240 -1 | -0% | -$2 |
|
|
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
| $462K | 0.74% | 197,345 | – | – |
|
7
Pulmatrix
PULM
$18M
| $374K | 0.6% | 359,441 | – | – |
|
|
8
Cartesian Therapeutics
RNAC
$261M
| – | – | -2,773,479 | Closed | -$12.6M |
|